Featured Research

from universities, journals, and other organizations

New genetic framework could help explain drug side effects

Date:
April 22, 2010
Source:
NIH/National Institute of General Medical Sciences
Summary:
In a major step toward predicting adverse drug reactions, systems biologists have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias. The new framework could be used to study other cardiac disorders and certain neurological diseases, including epilepsy and autism, and could aid the advance of personalized medicine.

This network map shows the overlap (green) between the long QT syndrome (yellow) and epilepsy (blue) protein-interaction neighborhoods located within the human interactome.
Credit: Seth Berger, Mount Sinai School of Medicine

In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias. The new framework could be used to study other cardiac disorders and certain neurological diseases, including epilepsy and autism, and could aid the advance of personalized medicine.

Since the completion of the Human Genome Project 10 years ago, scientists have compiled vast amounts of data about our genes and the proteins they make. From this information, they know where genes are located, which mutations lead to disease and how proteins interact with each other.

Researchers also better understand how slight genetic variations, or single-nucleotide polymorphisms (SNPs), in each of our genomes can alter our individual responses to medications.

The Mount Sinai researchers now have taken the next step: They have integrated this genetic information into a framework that can detect and predict a drug's dangerous action. Their results appear in the April 20 issue of Science Signaling.

Led by biochemist Ravi Iyengar, the researchers specifically wanted to understand how drugs can produce a side effect similar to the heart arrhythmias seen in people with a congenital condition called long QT syndrome, which causes a prolonged "QT interval" during the heart's electrical cycle.

"Many drugs, including some that treat nausea or others that treat acid reflux, are known to cause arrhythmias," says Iyengar, who directs one of the National Centers for Systems Biology funded by NIH's National Institute of General Medical Sciences (NIGMS). "By doing a network analysis, one can start to figure out the common mechanism."

Scientists have identified 13 genes associated with long QT, and the Iyengar team hypothesized that the drugs that cause the arrhythmias act upon the genes' proteins, as well as partnering and neighboring proteins.

To prove this, the researchers started with the currently known human interactome -- a map of some 11,000 human proteins and their interactions. Using computation, they narrowed it down to the proteins associated with the long QT genes.

They found that these 1,629 proteins formed their own area, or "neighborhood," within the interactome. About one-quarter of the proteins also belonged to 31 other disease neighborhoods, including those for other arrhythmia-related diseases, congestive heart failure, insomnia, autism, schizophrenia and epilepsy.

Iyengar says these results show that complex diseases can have identifiable boundaries yet may share common molecular features. The overlap, he adds, also indicates that people who have one disease may have the propensity to develop the others.

Mapping the long QT neighborhood let the Iyengar group explore the relationship between these proteins and drugs that cause arrhythmias. The researchers used several databases, including the U.S. Food and Drug Administration's Adverse Events Reporting System, to find that drugs known to cause long QT do act on proteins within the local neighborhood. The framework also identified other drugs likely to cause heart arrhythmias.

"One can start to explain why these adverse drug events are occurring," says Iyengar.

Using genome-wide association studies that look at genetic variation across a population, the researchers also identified additional SNPs that may serve as biological markers for QT interval-related diseases and potentially for how an individual might respond to certain drugs.

"The ability to predict these variations and adverse drug events is a true research advance," says Sarah Dunsmore, a physiologist at NIGMS. "The work also demonstrates a practical, real-life application of systems biology, a relatively young field that is still looking for new ways to integrate vast and complex information into insightful biomedical knowledge and applications."

While Iyengar says the framework is just the first step toward predicting a drug's adverse actions, he and others can use it to generate new hypotheses to test in the lab or to help improve drug design and development. The Iyengar group is already developing a similar framework for cancer drugs.

The ultimate goal, explains Iyengar, is for doctors to use the framework as a tool for choosing the safest medications for each patient.


Story Source:

The above story is based on materials provided by NIH/National Institute of General Medical Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. I. Berger, A. Ma'ayan, R. Iyengar. Systems Pharmacology of Arrhythmias. Science Signaling, 2010; 3 (118): ra30 DOI: 10.1126/scisignal.2000723

Cite This Page:

NIH/National Institute of General Medical Sciences. "New genetic framework could help explain drug side effects." ScienceDaily. ScienceDaily, 22 April 2010. <www.sciencedaily.com/releases/2010/04/100420174127.htm>.
NIH/National Institute of General Medical Sciences. (2010, April 22). New genetic framework could help explain drug side effects. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/04/100420174127.htm
NIH/National Institute of General Medical Sciences. "New genetic framework could help explain drug side effects." ScienceDaily. www.sciencedaily.com/releases/2010/04/100420174127.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins